CERVAVAC, India’s first indigenously developed gender-neutral quadrivalent Human Papillomavirus (HPV) vaccine manufactured by the Serum Institute of India (SII), has received World Health Organization (WHO) prequalification, marking a major milestone for India’s HPV vaccine programme and global immunisation efforts. The WHO prequalification became effective on

Robotic-assisted surgery is rapidly expanding across India, with Delhi-NCR emerging as the country's leading hub for robotic surgical systems and procedures, according to data presented at the Society of Robotic Surgery (SRS) India 2026 conference. Delhi-NCR currently has 39 hospitals equipped with robotic surgical systems, including

Kerala is set to establish the Keralam Institute of Organ and Tissue Transplant in Kozhikode within 30 months, Chief Minister V D Satheesan announced. The institute will come up on 20 acres at Chevayur Golf Link Road at a reported cost of ₹271 crore.The new

The Department of Pharmaceuticals (DoP) has approved around ₹1,600 crore in financial assistance for 41 pharma and MedTech innovation projects under the first round of the Promotion of Research and Innovation in Pharma-MedTech Sector (PRIP) scheme. The approved projects are expected to attract an additional

Stryker has launched Mako 4 SmartRobotics™ in India, bringing its fourth-generation robotic-arm assisted technology to the country's joint replacement market. The platform combines patient-specific planning, robotic technology and haptic guidance across Mako Total Knee, Mako Partial Knee and Mako Total Hip with Advanced Primary and

Cryoviva Life Sciences has been recognised with the Kalam Medal of Excellence in Genomic Innovation at The Next Gene – India’s BioScience Summit 2026, for the continuous effort of innovation from the company that contributes significantly to the development of the biosciences and genomics landscape.

The Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, has partnered with the Indian Institute of Technology Delhi (IIT Delhi) to develop an indigenous artificial intelligence (AI) tool aimed at enabling earlier detection of breast cancer among Indian women. The collaboration involves a Memorandum of

The Maharashtra Food and Drug Administration (FDA) has cancelled the drug sale and distribution licences of Cipla Pharma & Life Sciences Ltd’s warehouse in Wadki, Pune, citing alleged violations involving medicine packaging, storage conditions and inventory management. The action follows an inspection concerning Reactin Plus Tablets,